About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in California | 705 Studies

Clinical Trials Ovarian CancerCalifornia

Ovarian Cancer Clinical Trials in California

Find 705 clinical trials for ovarian cancer near California. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 705 trials

CompletedRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaRATIONALE: Monoclonal antibodies, such as RAV12, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00101972·Santa Monica, California and 4 others CompletedPaclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005046·Orange, California and 4 others TerminatedCapecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006812·Birmingham, Alabama and 30 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesRATIONALE: A Web site for stem cell transplant health information and support may be effective in helping parents improve their health-related knowledge, skills, and quality of…NCT00782145·Duarte, California and 5 others

CompletedIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerThis phase I trial is studying how well ipilimumab works after allogeneic stem cell transplant in treating patients with persistent or progressive cancer.NCT00060372·La Jolla, California and 4 others

CompletedOlvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerThe purpose of this study is to determine if Olvi-Vec oncolytic immunotherapy is well tolerated with anti-tumor activity in patients diagnosed with recurrent or refractory ovarian…NCT02759588·Newport Beach, California and 1 other

TerminatedClinical Trial for Ovarian Cancer (OvaRex®)This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients.NCT00050375·Huntsville, Alabama and 61 others

RecruitingA Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesATLAS-101 is a Phase I/II clinical trial of AMXI-5001 in adult participants with advanced malignancies who have previously failed other therapies. The study has two phases.NCT04503265·Los Angeles, California and 3 others

CompletedSunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian CancerThis phase II trial studies the side effects of sunitinib malate and how well it works in treating patients with ovarian cancer that is persistent or has come back.NCT00979992·Birmingham, Alabama and 96 others

WithdrawnVirtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast CancerThis clinical trial tests feasibility, acceptability and how well a virtual mental health intervention, compared to enhanced usual care consisting of an educational intervention…NCT07226102·Arcadia, California and 11 others

Active not recruitingPalbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers.NCT05554367·Birmingham, Alabama and 264 others

CompletedA Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis is a Phase III, global, double-blind, 2-arm randomized study designed to compare the efficacy and safety of atezolizumab + paclitaxel + carboplatin + bevacizumab versus…NCT03038100·Phoenix, Arizona and 267 others

Active not recruitingStudy to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian CancerTo compare the efficacy of olaparib in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced…NCT01081951·Stanford, California and 52 others

UnknownIMX-110 in Patients With Advanced Solid TumorsPhase 1 is an open-label, multi-center dose escalation/dose expansion study designed to assess the safety, tolerability and pharmacokinetics (PK) for the recommended phase 2 dose…NCT03382340·Santa Monica, California and 1 other

RecruitingClinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and TreatmentThe investigators will recruit and enroll individuals that may have the KRAS-variant or other microRNA binding site mutations to join registry studies.NCT02253251·Los Angeles, California

RecruitingA Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsThis is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and…NCT05932862·Fountain Valley, California and 15 others

CompletedLUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian CancerThe trial will be performed to evaluate if BIBF 1120 in combination with paclitaxel and carboplatin is more effective than placebo in combination with paclitaxel and carboplatin…NCT01015118·Tucson, Arizona and 280 others

CompletedStudy of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersPhase 1a/1b does-escalation study of cabiralizumab alone and with nivolumab in advanced solid tumors.NCT02526017·Scottsdale, Arizona and 38 others

TerminatedA Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell CarcinomaThis is a study to determine the safety of CDX-014 and effectiveness (how well the drug works).NCT02837991·Scottsdale, Arizona and 4 others

CompletedCabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerThis randomized phase II trial studies how well giving cabozantinib-s-malate or paclitaxel works in treating patients with persistent or recurrent epithelial ovarian, fallopian…NCT01716715·Mobile, Alabama and 172 others

PreviousPage 4 of 36Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia